ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 174.02%
This Quarter Est. Return
1 Year Est. Return
+174.02%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$616M
AUM Growth
+$96.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
239
New
Increased
Reduced
Closed

Top Buys

1
+$52.1M
2
+$20.5M
3
+$14M
4
CTMX icon
CytomX Therapeutics
CTMX
+$6.89M
5
ABVX
Abivax
ABVX
+$6.59M

Top Sells

1
+$17.4M
2
+$8.63M
3
+$6.94M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$6.34M
5
AVR
Anteris Technologies
AVR
+$4.35M

Sector Composition

1 Healthcare 83.61%
2 Financials 2.95%
3 Consumer Discretionary 0%
4 Industrials 0%
5 Utilities 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NRIX icon
126
Nurix Therapeutics
NRIX
$1.3B
$355K 0.05%
31,200
+10,000
MDGL icon
127
Madrigal Pharmaceuticals
MDGL
$12B
$319K 0.05%
1,054
-436
GPCR icon
128
Structure Therapeutics
GPCR
$2.23B
$311K 0.05%
15,000
-20,619
STOK icon
129
Stoke Therapeutics
STOK
$1.51B
$310K 0.05%
27,285
-2,800
APLS icon
130
Apellis Pharmaceuticals
APLS
$2.57B
$294K 0.05%
17,000
ANSC
131
Agriculture & Natural Solutions Acquisition Corp
ANSC
$477M
$294K 0.05%
27,062
-20,000
JAZZ icon
132
Jazz Pharmaceuticals
JAZZ
$8.57B
$292K 0.04%
+2,750
GOSS icon
133
Gossamer Bio
GOSS
$627M
$279K 0.04%
227,228
BMRN icon
134
BioMarin Pharmaceuticals
BMRN
$10.5B
$269K 0.04%
4,900
ITOS
135
DELISTED
iTeos Therapeutics
ITOS
$269K 0.04%
26,937
-74,159
UCFI
136
CN Healthy Food Tech Group
UCFI
$258K 0.04%
25,000
SMMT icon
137
Summit Therapeutics
SMMT
$13.4B
$255K 0.04%
+12,000
VYGR icon
138
Voyager Therapeutics
VYGR
$219M
$249K 0.04%
79,945
+4,400
TXMD icon
139
TherapeuticsMD
TXMD
$22.7M
$243K 0.04%
209,210
-60,950
ASND icon
140
Ascendis Pharma
ASND
$12.5B
$242K 0.04%
1,402
QNCX icon
141
Quince Therapeutics
QNCX
$90.2M
$236K 0.04%
142,958
CNTX icon
142
Context Therapeutics
CNTX
$107M
$230K 0.04%
351,094
DYN icon
143
Dyne Therapeutics
DYN
$2.68B
$220K 0.03%
23,063
-7,036
BCAX
144
Bicara Therapeutics
BCAX
$810M
$213K 0.03%
+22,875
KURA icon
145
Kura Oncology
KURA
$975M
$198K 0.03%
34,300
+9,300
DAWN icon
146
Day One Biopharmaceuticals
DAWN
$904M
$182K 0.03%
28,023
RXRX icon
147
Recursion Pharmaceuticals
RXRX
$2.16B
$177K 0.03%
35,000
+20,000
TRVI icon
148
Trevi Therapeutics
TRVI
$1.38B
$164K 0.03%
+30,000
CLBR
149
DELISTED
Colombier Acquisition Corp II
CLBR
$155K 0.02%
10,000
-8,513
AVXL icon
150
Anavex Life Sciences
AVXL
$314M
$150K 0.02%
16,221
4 5
6
7 8